Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
35 Upcoming Advancements: 12 Novel Anti-Obesity Medications in the Pipeline Multiple anti-obesity medications have been approved or are undergoing clinical trials
We believe that Gs-coupled GPCRs in intestinal L-cells, the main pathway for GLP-1 secretion, could serve as novel drug targets by acting as primary signals for GLP-1 secretion
While Novo can produce ~80M Wegovy auto-injectors in the US right now, there are estimates that its on its way to producing ~250M in the US (and ~250-300M outside of the US) by 2030
Mounjaro (tirzepatide) is an injectable medication licensed for the treatment of type 2 diabetes mellitus and chronic weight management
This includes the type 2 diabetes market and the obesity market, as Lilly is looking to get orforglipron approved for both diseases
On the day of your PrecisionTX treatment, youll start with a pre-operative check-in with your treating physician
